Fluoxetine recalls
Fluoxetine products have been recalled 7 times, most recently on 11 Jun 2025. The recalling company is usually Teva Pharmaceuticals U. The most common reason is nitrosamine impurity.
Total recalls7since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 11 Jun 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 7 100%Class III 0 0%
Why fluoxetine is recalled
Companies
Product types
By year
All fluoxetine recalls, newest first
7 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Fluoxetine Tablets, USP, 20 mg recalled by Torrent PharmaFluoxetine | Torrent Pharma | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Fluoxetine Tablets, USP, 20 mg Carton ( Unit-dose) recalledFluoxetine | Torrent Pharma | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Fluoxetine Capsules USP, 10 mg recalled by Teva Pharmaceuticals UFluoxetine | Teva Pharmaceuticals U | Potency & Assay | Nationwide |
| Drug | CLASS II | Fluoxetine Capsules USP, 20 mg recalled by Teva Pharmaceuticals UFluoxetine | Teva Pharmaceuticals U | Potency & Assay | Nationwide |
| Drug | CLASS II | Fluoxetine Capsules, USP, 20 mg recalled by Legacy PharmaceuticalFluoxetine | Legacy Pharmaceutical Packaging | Packaging Defects | Nationwide |
| Drug | CLASS II | Fluoxetine Capsules USP, 10 mg recalled by Teva Pharmaceuticals UFluoxetine | Teva Pharmaceuticals U | Other | Nationwide |
| Drug | CLASS II | Fluoxetine Capsules USP, 20 mg recalled by Teva Pharmaceuticals UFluoxetine | Teva Pharmaceuticals U | Packaging Defects | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.